199 related articles for article (PubMed ID: 15967736)
1. The role of airway epithelium and blood neutrophils in the inflammatory response in cystic fibrosis.
Terheggen-Lagro SW; Rijkers GT; van der Ent CK
J Cyst Fibros; 2005 Aug; 4 Suppl 2():15-23. PubMed ID: 15967736
[TBL] [Abstract][Full Text] [Related]
2. [Early bronchial inflammation in cystic fibrosis].
Puchelle E
J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
[TBL] [Abstract][Full Text] [Related]
3. Airway epithelial cell inflammatory signalling in cystic fibrosis.
Jacquot J; Tabary O; Le Rouzic P; Clement A
Int J Biochem Cell Biol; 2008; 40(9):1703-15. PubMed ID: 18434235
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease.
Conese M; Copreni E; Di Gioia S; De Rinaldis P; Fumarulo R
J Cyst Fibros; 2003 Sep; 2(3):129-35. PubMed ID: 15463861
[TBL] [Abstract][Full Text] [Related]
5. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
Mall MA
Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
[TBL] [Abstract][Full Text] [Related]
6. Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells.
Noël S; Wilke M; Bot AG; De Jonge HR; Becq F
J Pharmacol Exp Ther; 2008 Jun; 325(3):1016-23. PubMed ID: 18309088
[TBL] [Abstract][Full Text] [Related]
7. [Physiopathology of cystic fibrosis lung disease].
Chinet T
Rev Mal Respir; 1999 Jun; 16(3):339-45. PubMed ID: 10472642
[TBL] [Abstract][Full Text] [Related]
8. Role of CFTR in airway disease.
Pilewski JM; Frizzell RA
Physiol Rev; 1999 Jan; 79(1 Suppl):S215-55. PubMed ID: 9922383
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effect of miglustat in bronchial epithelial cells.
Dechecchi MC; Nicolis E; Norez C; Bezzerri V; Borgatti M; Mancini I; Rizzotti P; Ribeiro CM; Gambari R; Becq F; Cabrini G
J Cyst Fibros; 2008 Nov; 7(6):555-65. PubMed ID: 18815075
[TBL] [Abstract][Full Text] [Related]
10. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
Tarran R; Donaldson S; Boucher RC
Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
Witko-Sarsat V; Sermet-Gaudelus I; Lenoir G; Descamps-Latscha B
Mediators Inflamm; 1999; 8(1):7-11. PubMed ID: 10704083
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by TNF-alpha and IL-4 of cationic lipid mediated gene transfer in cystic fibrosis tracheal gland cells.
Bastonero S; Gargouri M; Ortiou S; Guéant JL; Merten MD
J Gene Med; 2005 Nov; 7(11):1439-49. PubMed ID: 16001392
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis: a disease of vulnerability to airway surface dehydration.
Boucher RC
Trends Mol Med; 2007 Jun; 13(6):231-40. PubMed ID: 17524805
[TBL] [Abstract][Full Text] [Related]
14. Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis.
Marcet B; Boeynaems JM
Pharmacol Ther; 2006 Dec; 112(3):719-32. PubMed ID: 16828872
[TBL] [Abstract][Full Text] [Related]
15. [Benzamil and mucoviscidosis. Primary culture of nasal mucosa as an electrophysiologic in vitro model].
Blank U; Glanz H; Eistert B; Fryen A; Lindemann H; Hüls G; Clauss W; Weber WM
HNO; 1996 Apr; 44(4):172-7. PubMed ID: 8655347
[TBL] [Abstract][Full Text] [Related]
16. Increased NaCl-induced interleukin-8 production by human bronchial epithelial cells is enhanced by the DeltaF508/W1282X mutation of the cystic fibrosis transmembrane conductance regulator gene.
Chan MM; Chmura K; Chan ED
Cytokine; 2006 Mar; 33(6):309-16. PubMed ID: 16647268
[TBL] [Abstract][Full Text] [Related]
17. Abnormal ion content, hydration and granule expansion of the secretory granules from cystic fibrosis airway glandular cells.
Baconnais S; Delavoie F; Zahm JM; Milliot M; Terryn C; Castillon N; Banchet V; Michel J; Danos O; Merten M; Chinet T; Zierold K; Bonnet N; Puchelle E; Balossier G
Exp Cell Res; 2005 Oct; 309(2):296-304. PubMed ID: 16051214
[TBL] [Abstract][Full Text] [Related]
18. Altered terminal glycosylation and the pathophysiology of CF lung disease.
Rhim AD; Stoykova LI; Trindade AJ; Glick MC; Scanlin TF
J Cyst Fibros; 2004 Aug; 3 Suppl 2():95-6. PubMed ID: 15463936
[TBL] [Abstract][Full Text] [Related]
19. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.
Verhaeghe C; Remouchamps C; Hennuy B; Vanderplasschen A; Chariot A; Tabruyn SP; Oury C; Bours V
Biochem Pharmacol; 2007 Jun; 73(12):1982-94. PubMed ID: 17466952
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory effect of sodium 4-phenylbutyrate in deltaF508-cystic fibrosis transmembrane conductance regulator lung epithelial cells: involvement of extracellular signal-regulated protein kinase 1/2 and c-Jun-NH2-terminal kinase signaling.
Roque T; Boncoeur E; Saint-Criq V; Bonvin E; Clement A; Tabary O; Jacquot J
J Pharmacol Exp Ther; 2008 Sep; 326(3):949-56. PubMed ID: 18574003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
